Ramiro Ribeiro - 02 Jan 2026 Form 4 Insider Report for EyePoint, Inc. (EYPT)

Role
Chief Medical Officer
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
02 Jan 2026
Net transactions value
-$111,400
Form type
4
Filing time
06 Jan 2026, 16:47:59 UTC
Previous filing
12 Nov 2025
Next filing
07 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ribeiro Ramiro Chief Medical Officer C/O EYEPOINT, INC, 480 PLEASANT STREET, SUITE C400, WATERTOWN /s/ Ron Honig, Attorney-in-Fact 06 Jan 2026 0002013623

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +19,667 $0.000000 19,667 03 Jan 2026 Direct
transaction EYPT Common Stock Tax liability $111,400 -6,373 -32% $17.48 13,294 03 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +85,700 $0.000000 85,700 02 Jan 2026 Common Stock 85,700 $0.000000 Direct F2
transaction EYPT Stock Option (Right to Buy) Award $0 +171,400 $0.000000 171,400 02 Jan 2026 Common Stock 171,400 $17.48 Direct F3
transaction EYPT Restricted Stock Units Options Exercise $0 -19,667 -33% $0.000000 39,333 03 Jan 2026 Common Stock 19,667 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
F2 The restricted stock units will vest in three ratable annual installments beginning January 2, 2027.
F3 The option to purchase will vest and become exercisable as follows: 25% at January 2, 2027 and the remainder ratably, on a monthly basis, over the remaining three years.
F4 The restricted stock units vest in three ratable annual installments beginning January 3, 2026.